| 1. |
左婷婷, 鄭榮壽, 曾紅梅, 等. 中國胃癌流行病學現狀. 中國腫瘤臨床, 2017, 44(1): 52-58.
|
| 2. |
Marinkovi? M, ?prung M, Buljuba?i? M, et al. Autophagy modulation in cancer: current knowledge on action and therapy. Oxid Med Cell Longev, 2018, 2018: 8023821.
|
| 3. |
余招焱, 王潤華, 張忠民, 等. 自噬及其在胃癌中的研究進展. 中國普外基礎與臨床雜志, 2015, 22(1): 121-125.
|
| 4. |
Sipos F, Székely H, Kis ID, et al. Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer. World J Gastroenterol, 2017, 23(46): 8109-8119.
|
| 5. |
Khambu B, Huda N, Chen X, et al. HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers. J Clin Invest, 2018, 128(6): 2419-2435.
|
| 6. |
Grootaert MOJ, Roth L, Schrijvers DM, et al. Defective autophagy in atherosclerosis: To die or to senesce? Oxid Med Cell Longev, 2018, 2018: 7687083.
|
| 7. |
Fang C, Gu L, Smerin D, et al. The interrelation between reactive oxygen species and autophagy in neurological disorders. Oxid Med Cell Longev, 2017, 2017: 8495160.
|
| 8. |
崔丹蕊, 劉波, 劉偉. 細胞自噬與腫瘤發生關系的研究進展. 中國科學: 生命科學, 2015, 45(6): 593-603.
|
| 9. |
杜云廣, 王書華. 細胞自噬及其與腫瘤發生關系的研究進展. 河北北方學院學報(自然科學版), 2018, 34(2): 49-55.
|
| 10. |
Chen YB, Hou JH, Feng XY, et al. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. J Surg Oncol, 2012, 105(6): 542-547.
|
| 11. |
Zhou WH, Tang F, Xu J, et al. Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. Autophagy, 2012, 8(3): 389-400.
|
| 12. |
Yu M, Gou WF, Zhao S, et al. Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol, 2013, 34(2): 1071-1083.
|
| 13. |
Wang Y, Xie J, Wang H, et al. Beclin-1 suppresses gastric cancer progression by promoting apoptosis and reducing cell migration. Oncol Lett, 2017, 14(6): 6857-6862.
|
| 14. |
Huang X, Wang C, Sun J, et al. Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis. Oncol Lett, 2018, 15(1): 947-955.
|
| 15. |
羅小月, 嚴倩, 彭美玲, 等. Beclin1 和 LC3 在胃癌組織中的表達水平和臨床意義. 湖南師范大學學報(醫學版), 2016, 13(4): 4-7.
|
| 16. |
李良慶, 潘敦, 林振孟. 自噬相關基因 Beclin1 和微管相關蛋白輕鏈 3 在胃癌組織中的表達及臨床意義. 中華實驗外科雜志, 2014, 31(3): 508-510.
|
| 17. |
袁文敏, 林梅. 胃癌組織 Beclin-1 與 Bcl-2 的表達及其意義. 青島大學, 2016.
|
| 18. |
黃俊玲, 鐘騰猛, 黃贊松, 等. 自噬因子 Beclin 1 和 LC3 表達與胃癌臨床病理特征的相關性研究. 實用癌癥雜志, 2016, 31(4): 530-532.
|
| 19. |
宋華勇, 馬磊. 自噬相關基因 Beclin 1 和微管相關蛋白輕鏈 3 在胃癌組織中的表達及臨床意義. 泰山醫學院學報, 2017, 38(7): 731-733.
|
| 20. |
Yin Q, Feng W, Shen X, et al. Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis. Biosci Rep, 2018, 38(5): pii: BSR20180516.
|
| 21. |
Ahn CH, Jeong EG, Lee JW, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS, 2007, 115(12): 1344-1349.
|
| 22. |
Xia P, Wang JJ, Zhao BB, et al. The role of beclin-1 expression in patients with gastric cancer: a meta-analysis. Tumour Biol, 2013, 34(6): 3303-3307.
|
| 23. |
Liang C, Li W, Ge H, et al. Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis. Onco Targets Ther, 2018, 11: 2387-2397.
|
| 24. |
高金雪, 吳清明, 劉丹. 大腸癌組織自噬相關蛋白 Beclin1 表達意義 Meta 分析. 中華腫瘤防治雜志, 2017, 24(4): 273-277.
|
| 25. |
霍小蕾, 王金勝, 張毅強, 等. FoxO1 及自噬相關基因 Beclin1 和 MAPLC3 在胃癌組織的表達及意義. 西安交通大學學報(醫學版), 2017, 38(5): 773-776.
|
| 26. |
鄭華川, 申道福, 楊雪峰, 等. Beclin 1 表達在胃癌發生和演進中的臨床病理意義及作用機制. 中國醫科大學學報, 2015, 44(12): 1061-1065.
|
| 27. |
林哲洙, 張紅, 張磊, 等. Beclin1 基因在胃癌發生和演進中的分子作用機制. 中國老年學雜志, 2015, (16): 4477-4479.
|
| 28. |
Qin W, Li C, Zheng W, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells. Oncotarget, 2015, 6(37): 39839-39854.
|